Yalcin Erzurumlu (Yalçın Erzurumlu, Yalcın Erzurumlu, Halil Aşcı)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Endoplasmic Reticulum

Quality Control

Estrogen Receptor

Lipopolysaccharide Induced

Top Venues

Journal of clinical medicine

Journal of natural medicines

Cannabis and cannabinoid research

Metabolic brain disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yalcin Erzurumlu, Deniz Catakli
Cannabidiol Enhances the Anticancer Activity of Etoposide on Prostate Cancer Cells. Cannabis and cannabinoid research (2024)
Yalcin Erzurumlu, Hatice Kubra Doğan, Deniz Catakli
New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling. Journal of biochemical and molecular toxicology 38 (1) (2024)
Esra Nurlu Temel, Mehtap Savran, Yalcin Erzurumlu, Nursel Hasseyid, Halil Ibrahim Buyukbayram, Gozde Okuyucu, Mehmet Abdulkadir Sevuk, Ozlem Ozmen, Ayse Coskun Beyan
The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. Journal of clinical medicine 12 (5) (2023)
Yalcin Erzurumlu, Deniz Catakli, Hatice Kubra Doğan
Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells. Journal of natural medicines (2023)
Halil Aşçi, Mehtap Savran, Selcuk Comlekci, Mehmet M Sofu, Yalcin Erzurumlu, Ozlem Ozmen, Mine Kaynak, Mehmet E Sahin, Rumeysa Taner, Mustafa Gecin
Combined Pulsed Magnetic Field and Radiofrequency Electromagnetic Field Enhances MMP-9, Collagen-4, VEGF Synthesis to Improve Wound Healing Via Hif-1α/eNOS Pathway. Aesthetic plastic surgery (2023)
Yalcin Erzurumlu, Hatice Kubra Doğan, Deniz Catakli, Esra Aydogdu, Muhammed Tilahun Muhammed
Estrogens drive the endoplasmic reticulum-associated degradation and promote proto-oncogene c-Myc expression in prostate cancer cells by androgen receptor/estrogen receptor signaling. Journal of cell communication and signaling (2023)
Yalcin Erzurumlu, Deniz Catakli, Hatice Kubra Doğan
Circadian Oscillation Pattern of Endoplasmic Reticulum Quality Control (ERQC) Components in Human Embryonic Kidney HEK293 Cells. Journal of circadian rhythms 21 (2023)
Nasif Fatih Karakuyu, Mehtap Savran, Ibrahim Aydin Candan, Halil Ibrahim Büyükbayram, Yalcin Erzurumlu
Investigation of cardioprotective effect of lercanidipine on doxorubicin-induced cardiotoxicity. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Mehtap Savran, Sanem Asci, Kanat Gülle, Rahime Aslankoc, Halil Aşçi, Nasif Fatih Karakuyu, Yalcin Erzurumlu, Mine Kaynak
Agomelatine ameliorates doxorubicin-induced cortical and hippocampal brain injury via inhibition of TNF-alpha/NF-kB pathway. Toxicology mechanisms and methods (2023)
Esra Nurlu Temel, Mehtap Savran, Yalcin Erzurumlu, Nursel Hasseyid, Halil Ibrahim Buyukbayram, Gozde Okuyucu, Mehmet Abdulkadir Sevuk, Ozlem Ozmen, Ayse Coskun Beyan
The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. Journal of clinical medicine 12 (5) (2023)
Gülin Ozdamar Unal, Halil Aşçi, Yalcin Erzurumlu, İlter İlhan, Nursel Hasseyid, Ozlem Ozmen
Dexpanthenol may protect the brain against lipopolysaccharide induced neuroinflammation via anti-oxidant action and regulating CREB/BDNF signaling. Immunopharmacology and immunotoxicology 44 (2) (2022)
Yalcin Erzurumlu, Hatice Kubra Doğan, Deniz Catakli
Progesterone regulates the endoplasmic reticulum-associated degradation and Unfolded Protein Response axis by mimicking the androgenic stimulation in prostate cancer cells. Molecular biology reports (2022)
Meltem Özgöçmen, Yalcin Erzurumlu, Hatice Kubra Doğan, İlter İlhan, Şakir Pekgöz, Ali Mustafaoğlu
A study on Wistar Albino rats: investigating protective role of ramelteon on liver damage caused by methotrexate. Drug and chemical toxicology (2021)
Fatma Nihan Cankara, Caner Gunaydin, Zulfinaz Betul Celik, Yasemin Şahin, Şakir Pekgöz, Yalcin Erzurumlu, Kanat Gülle
Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity. Metabolic brain disease 36 (2) (2020)